Cypress Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,923
| Closed | -$53.8K | – | 274 |
|
|
2024
Q2 | $53.8K | Buy |
+1,923
| New | +$53.8K | 0.01% | 111 |
|
|
2023
Q4 | – | Sell |
-49,208
| Closed | -$1.63M | – | 79 |
|
|
2023
Q3 | $1.63M | Buy |
49,208
+1,788
| +4% | +$59.3K | 0.48% | 42 |
|
|
2023
Q2 | $1.74M | Buy |
47,420
+1,535
| +3% | +$56.3K | 0.5% | 40 |
|
|
2023
Q1 | $1.87M | Buy |
45,885
+1,728
| +4% | +$70.5K | 0.59% | 33 |
|
|
2022
Q4 | $2.26M | Buy |
44,157
+437
| +1% | +$22.4K | 0.71% | 28 |
|
|
2022
Q3 | $1.91M | Buy |
43,720
+1,792
| +4% | +$78.4K | 0.67% | 28 |
|
|
2022
Q2 | $2.2M | Sell |
41,928
-1,411
| -3% | -$74K | 0.31% | 53 |
|
|
2022
Q1 | $2.24M | Buy |
43,339
+1,902
| +5% | +$98.5K | 0.28% | 55 |
|
|
2021
Q4 | $2.45M | Buy |
41,437
+154
| +0.4% | +$9.09K | 0.28% | 53 |
|
|
2021
Q3 | $1.78M | Buy |
41,283
+4,363
| +12% | +$188K | 0.23% | 71 |
|
|
2021
Q2 | $1.45M | Buy |
36,920
+5,809
| +19% | +$228K | 1.41% | 33 |
|
|
2021
Q1 | $1.13M | Buy |
31,111
+3,577
| +13% | +$130K | 0.46% | 53 |
|
|
2020
Q4 | $1.01M | Sell |
27,534
-1,523
| -5% | -$56.1K | 0.46% | 48 |
|
|
2020
Q3 | $1.02M | Sell |
29,057
-3,102
| -10% | -$108K | 0.47% | 44 |
|
|
2020
Q2 | $998K | Buy |
+32,159
| New | +$998K | 0.44% | 47 |
|
|
2019
Q4 | $775K | Buy |
20,843
+1,098
| +6% | +$40.8K | 0.33% | 54 |
|
|
2019
Q3 | $673K | Buy |
19,745
+1,447
| +8% | +$49.3K | 0.31% | 53 |
|
|
2019
Q2 | $752K | Buy |
18,298
+762
| +4% | +$31.3K | 0.34% | 44 |
|
|
2019
Q1 | $707K | Buy |
17,536
+1,229
| +8% | +$49.6K | 0.29% | 45 |
|
|
2018
Q4 | $675K | Buy |
+16,307
| New | +$675K | 0.31% | 38 |
|